A blood disease specialist (hematologist) can be consulted if the blood count is found or believed to be in an abnormal state, such as anemia or leukocytic or platelet changes. Symptoms may include fatigue, reduced performance, fever, weight loss or bleeding diathesis. Blood diseases can affect either the blood cells or blood plasma. Patients undergo a thorough examination and often bone marrow samples are collected from them as well. To reach a diagnosis and begin treatments quickly, the samples are examined in laboratories specialized in blood disease diagnostics. Over the last few years, treatments for malignant blood diseases have developed significantly, and the majority of patients can be cured with cytotoxic chemotherapy or stem cell transplantations.

Blood Coagulation Disorders

A blood coagulation disorder specialist focuses on the comprehensive evaluation and treatment of thrombic and hemorrhagic problems. The objective may involve detecting thrombophilia, preventing or monitoring thrombi, or to give another example, preparing coagulation disorder patients for procedures.

The Coagulation Disorder Unit is a unique team of leading blood coagulation disorder experts in Finland, working under the supervision of the Hematology Clinic at the Helsinki University Hospital. Duties include early identification of coagulation disorders and the development of diagnostics, treatment and monitoring in accordance with international practices.

Health care professionals throughout Finland can consult the Blood Coagulation Disorder Unit. Key functions of the service include consultations and patient Info as well as collaboration with specialists from other fields.

Problems that are typically addressed by the Coagulalation Disorder Unit include prevention of thrombi, selection and monitoring of anticoagulant treatment, follow-up treatment of venous thrombi and pulmonary embolisms, identification of thrombophilia and probing the occurrence of thrombi despite conventional medication. Other services include preparing patients with severe coagulation disorders for procedures, monitoring during convalescence, treatment and laboratory monitoring of hemorrhagic complications and treatment and monitoring of hereditary and other hemorrhagic diseases.

More information is available at our Customer Service.